title: Successful chemotherapy and 90Y-DOTATOC in a patient with mediastinal highly aggressive neuroendocrine carcinoma.
authors.forename: Nicola
authors.initials: N
authors.lastname: Fazio
authors.forename: Chiara
authors.initials: C
authors.lastname: Grana
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Pelosi
authors.forename: Rosalba
authors.initials: R
authors.lastname: Torrisi
authors.forename: Giovanni
authors.initials: G
authors.lastname: Di Meglio
authors.forename: Nicoletta
authors.initials: N
authors.lastname: Tradati
authors.forename: Katia
authors.initials: K
authors.lastname: Lorizzo
authors.forename: Filippo
authors.initials: F
authors.lastname: De Braud
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D018278:Carcinoma, Neuroendocrine / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary; D018450:Disease Progression; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008479:Mediastinal Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000175:diagnosis / Q000188:drug therapy*; D015282:Octreotide / Q000008:administration & dosage / Q000031:analogs & derivatives*; D012074:Remission Induction; D012307:Risk Factors; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D005047:Etoposide; C496730:90Y-octreotide, DOTA-Tyr(3)-; D016190:Carboplatin; D015282:Octreotide